Valuation: Edwards Lifesciences Corporation

Market Cap 52.8B 45.58B 42.76B 38.95B 73.23B 5,048B 74.25B 501B 196B 2,529B 198B 194B 8,413B P/E 2026 *
36.2x
P/E 2027 * 27.7x
Enterprise Value 49.17B 42.45B 39.82B 36.27B 68.2B 4,701B 69.14B 467B 183B 2,355B 185B 181B 7,835B EV / Sales 2026 *
7.27x
EV / Sales 2027 * 6.41x
Free-Float
86.96%
Yield 2026 *
-
Yield 2027 * -
1 day-0.86%
1 week-1.33%
Current month+5.51%
1 month+5.93%
3 months+10.22%
6 months+15.76%
Current year+6.52%
1 week 90.59
Extreme 90.59
93.91
1 month 81.16
Extreme 81.155
93.91
Current year 74.66
Extreme 74.66
96.29
1 year 72.3
Extreme 72.3
96.29
3 years 58.93
Extreme 58.93
96.29
5 years 58.93
Extreme 58.93
131.73
10 years 27.04
Extreme 27.04
131.73
Manager TitleAgeSince
Chief Executive Officer 58 11/05/2023
Director of Finance/CFO 43 29/05/2026
Chief Tech/Sci/R&D Officer 51 01/09/2025
Director TitleAgeSince
Chairman 69 07/05/2024
Director/Board Member 62 10/02/2015
Director/Board Member 58 11/05/2023
Date Insider Type Main position Quantity % Market Cap.
8/11/26 A Fiscal year

Executive/Senior Manager

1,857 0.0003%
7/30/26 A Sell

Executive/Senior Manager

-146 0.0000%
7/28/26 A Fiscal year

Executive/Senior Manager

28,884 0.0050%
Change 5-day change 1-year change 3-year change Capi.($)
-0.86%-1.33%+15.98%+18.20% 52.8B
-0.47%-2.36%+20.09%+9.25% 218B
+0.09%-3.22%-3.05%-19.85% 142B
-1.06%-0.78%-18.90%+34.56% 139B
-0.77%+1.92%-50.09%+0.96% 75.11B
-0.79%-1.29%-17.14%-16.13% 50.66B
-0.05%-0.18%+25.65%+22.84% 41.95B
-1.07%-0.98%+40.89%+49.27% 40.49B
-1.79%-0.78%-1.09%+5.82% 33.28B
-1.82%+0.15%-22.98%+33.72% 32.38B
Average -0.64%+2.04%-1.07%+13.86% 82.59B
Weighted average by Cap. -0.38%+1.31%-0.65%+10.24%

Financials

2026 *2027 *
Net sales 6.76B 5.84B 5.47B 4.99B 9.38B 646B 9.51B 64.17B 25.15B 324B 25.38B 24.83B 1,077B 7.43B 6.41B 6.02B 5.48B 10.3B 710B 10.45B 70.53B 27.64B 356B 27.89B 27.29B 1,184B
Net income 1.44B 1.24B 1.16B 1.06B 1.99B 137B 2.02B 13.63B 5.34B 68.75B 5.39B 5.27B 229B 1.9B 1.64B 1.54B 1.4B 2.63B 181B 2.67B 18.01B 7.06B 90.85B 7.12B 6.97B 302B
Net Debt -3.63B -3.13B -2.94B -2.68B -5.04B -347B -5.11B -34.47B -13.51B -174B -13.63B -13.34B -579B -5.19B -4.48B -4.21B -3.83B -7.21B -497B -7.31B -49.32B -19.33B -249B -19.5B -19.08B -828B
Logo Edwards Lifesciences Corporation
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows: - heart valves and surgery products (74%); - hemodynamic monitoring systems (9.1%); - other (16.9%): balloon catheters, artificial implants, etc. Net sales are distributed geographically as follows: the United States (58.4%), Europe (25%), Japan (5.8%) and other (10.8%).
Employees
16,000
Date Price Change Volume
17/08/26 $90.81 -0.86% 2,215,741
14/08/26 $91.60 -1.04% 2,856,892
13/08/26 $92.56 -0.53% 2,809,926
12/08/26 $93.05 -0.65% 2,340,306
11/08/26 $93.66 +1.77% 3,138,661
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
91.60USD
Average target price
100.96USD
Spread / Average Target
+10.22%

Quarterly revenue - Rate of surprise